Significant health disparities exist in both infection rates and outcomes for those with HIV, 19% of whom are women, the majority their reproductive years life African American. Utilizing Husserlian phenomenological methodology, purpose this study was to understand experiences women living HIV decision making, as well power dynamics within relationship if or how these shape decision-making. Dat...

Both CD4+ T cells and macrophages are major reservoirs of HIV-1. Previous study showed that HIV-1-specific cytolytic T lymphocytes (CTLs) hardly recognize HIV-1-infected CD4+ T cells because of Nef-mediated HLA class I down-regulation, suggesting that HIV-1 escapes from HIV-1-specific CTLs and continues to replicate in HIV-1-infected donors. On the other hand, the CTL recognition of HIV-1-infec...

You mention that you think you have HIV. It's not clear if you are basing this on a previous sexual experience, knowledge about a former partner, if you are having physical symptoms, or if you've tested positive. There are many resources to find out more information and also get tested for HIV. You can try contacting your city or state Department of Health to find testing sites. Planned Parenth...

Background: Anemia is a prevalent medical disorder during pregnancy, posing significant global public health burden. In developing countries like Nigeria, it remains major cause of maternal and perinatal morbidity mortality. Aim: To determine the red cell morphological patterns, peculiarities (clinical characteristics) anemia, associated risk factors including socio-demographic fa...

OBJECTIVE To examine the association between HIV-II infection and tuberculosis. DESIGN Cross sectional study comparing the prevalence of HIV-I and HIV-II infections in patients with tuberculosis and in blood donors. SETTING Abidjan, Ivory Coast, west Africa. PATIENTS 2043 consecutive ambulant patients with tuberculosis (confirmed pulmonary, presumed pulmonary, or extrapulmonary) and 2127 ...

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are widely used in combination therapies against HIV-1. However, emergent and transmitted drug resistance compromise their efficacy the clinical setting. Y181C is selected patients receiving nevirapine, etravirine rilpivirine, together with K103N most prevalent NNRTI-associated mutation HIV-infected patients. Herein, we report on design, ...

BACKGROUND Retrovirus infections among injecting drug users (IDUs), a core at-risk population for both HIV-1 and HTLV-I/II infections in Brazil, were assessed within an ongoing cooperative research. OBJECTIVE The study assessed the seroprevalences of HIV-1 and HTLV-I/II infections, as well as the prevalence of HIV-1 subtypes in a sample of IDUs from Rio de Janeiro, Brazil. An attempt to evalu...

background globally, almost 20% of cancers are related to infectious agents that can be prevented. oncogenicity refers to viruses that may cause cancers, more importantly in immunocompromised subjects such as transplant and hemodialysis patients. therefore, epidemiological studies are the first line for understanding the importance of these agents in public health, particularly, in mobile popul...